|Articles|May 20, 2021
Use of a MAbPac RP capillary column to monitor glycosylation site occupancy in therapeutics
Author(s)Thermo Fisher Scientific
A new approach using the novel, easy-to-connect Thermo Scientific MAbPac RP capillary column for determining glycosylation site occupancy of therapeutic antibodies from the analysis of their tryptic digest.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Novel Delivery Approaches of Biopharmaceuticals 2025
2
FAQ: What You Need to Know about the Current Antibody Pipeline
3
Samsung Biologics Bolsters US Manufacturing Network with GSK Facility Buy
4
GSK and CAMP4 Partner to Advance RNA-Targeting Therapeutics
5